Last reviewed · How we verify
Plasma-lyte (static group)
Plasma-Lyte is a balanced electrolyte solution that replaces fluid and electrolytes lost through dehydration, hemorrhage, or other medical conditions.
Plasma-Lyte is a balanced electrolyte solution that replaces fluid and electrolytes lost through dehydration, hemorrhage, or other medical conditions. Used for Fluid resuscitation and maintenance in dehydration, Perioperative fluid management, Hemorrhage and acute blood loss replacement.
At a glance
| Generic name | Plasma-lyte (static group) |
|---|---|
| Sponsor | Algemeen Ziekenhuis Maria Middelares |
| Drug class | Crystalloid intravenous fluid / Electrolyte replacement solution |
| Modality | Small molecule |
| Therapeutic area | Critical Care / Fluid and Electrolyte Management |
| Phase | FDA-approved |
Mechanism of action
Plasma-Lyte is a crystalloid intravenous fluid containing a physiologically balanced mixture of electrolytes (sodium, potassium, magnesium, calcium, chloride, acetate, and gluconate) designed to closely mimic plasma composition. It is used for fluid resuscitation and maintenance therapy to restore intravascular volume and correct electrolyte imbalances without causing hyperchloremic acidosis or other electrolyte disturbances associated with normal saline.
Approved indications
- Fluid resuscitation and maintenance in dehydration
- Perioperative fluid management
- Hemorrhage and acute blood loss replacement
- Electrolyte imbalance correction
Common side effects
- Hyperkalemia
- Hypokalemia
- Hypernatremia
- Hyponatremia
- Fluid overload / Pulmonary edema
- Phlebitis at infusion site
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Plasma-lyte (static group) CI brief — competitive landscape report
- Plasma-lyte (static group) updates RSS · CI watch RSS
- Algemeen Ziekenhuis Maria Middelares portfolio CI